Evolution of Bordetella pertussis over a 23-year period in France, 1996 to 2018
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Evolution of Bordetella pertussis over a 23-year period in France, 1996 to 2018
Authors
Keywords
-
Journal
Eurosurveillance
Volume 26, Issue 37, Pages -
Publisher
European Centre for Disease Control and Prevention (ECDC)
Online
2021-09-17
DOI
10.2807/1560-7917.es.2021.26.37.2001213
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The 112-Year Odyssey of Pertussis and Pertussis Vaccines—Mistakes Made and Implications for the Future
- (2019) James D Cherry Journal of the Pediatric Infectious Diseases Society
- Pertactin-deficient Bordetella pertussis isolates: evidence of increased circulation in Europe, 1998 to 2015
- (2019) Alex-Mikael Barkoff et al. Eurosurveillance
- Pertussis Prevention: Reasons for Resurgence, and Differences in the Current Acellular Pertussis Vaccines
- (2019) Susanna Esposito et al. Frontiers in Immunology
- Screening and Genomic Characterization of Filamentous Hemagglutinin-Deficient Bordetella pertussis
- (2018) Michael R. Weigand et al. INFECTION AND IMMUNITY
- An update of the global burden of pertussis in children younger than 5 years: a modelling study
- (2017) Karene Hoi Ting Yeung et al. LANCET INFECTIOUS DISEASES
- Antigenic and genetic characterization of Bordetella pertussis recovered from Quebec, Canada, 2002–2014: detection of a genetic shift
- (2016) Michelle Shuel et al. CANADIAN JOURNAL OF MICROBIOLOGY
- Monitoring the Impact of Vaccination on Pertussis in Infants Using an Active Hospital-based Pediatric Surveillance Network
- (2015) Sarah Tubiana et al. PEDIATRIC INFECTIOUS DISEASE JOURNAL
- Pertactin negative Bordetella pertussis demonstrates higher fitness under vaccine selection pressure in a mixed infection model
- (2015) Azadeh Safarchi et al. VACCINE
- Investigations into the emergence of pertactin-deficient Bordetella pertussis isolates in six European countries, 1996 to 2012
- (2014) A Zeddeman et al. Eurosurveillance
- Bordetella pertussisfimbriae (Fim): relevance for vaccines
- (2014) Andrew R Gorringe et al. Expert Review of Vaccines
- Pertactin deficient Bordetella pertussis present a better fitness in mice immunized with an acellular pertussis vaccine
- (2014) N. Hegerle et al. VACCINE
- Global Population Structure and Evolution of Bordetella pertussis and Their Relationship with Vaccination
- (2014) M. J. Bart et al. mBio
- Prevalence and Molecular Characterization of Pertactin-Deficient Bordetella pertussis in the United States
- (2013) L. C. Pawloski et al. Clinical and Vaccine Immunology
- Genetic Analysis of Bordetella pertussis Isolates from the 2008–2010 Pertussis Epidemic in Japan
- (2013) Yusuke Miyaji et al. PLoS One
- Evolution of French Bordetella pertussis and Bordetella parapertussis isolates: increase of Bordetellae not expressing pertactin
- (2012) N. Hegerle et al. CLINICAL MICROBIOLOGY AND INFECTION
- First report and detailed characterization of B. pertussis isolates not expressing pertussis toxin or pertactin
- (2009) V. Bouchez et al. VACCINE
- Bordetella pertussis Isolates in Finland: Serotype and Fimbrial Expression
- (2008) Eriikka Heikkinen et al. BMC MICROBIOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now